Product
SAR445419
2 clinical trials
2 indications
Indication
Allogeneic Stem Cell TransplantationIndication
Acute Myeloid LeukemiaClinical trial
A Phase 2, Single Arm, Multicohort, Open Label, Multicenter Trial of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Patients With High-risk Myeloid Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Status: Withdrawn, Estimated PCD: 2027-02-12
Clinical trial
A Phase I, Single-arm, Open Label, Dose Escalation, Multicenter Study of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)Status: Terminated, Estimated PCD: 2024-02-23